Mental Health

Pharmacists can learn about treatment of major depressive disorder.

The risk of depression in chronic obstructive pulmonary disease patients increases along with disease severity, according to the results of a new study.

According to the results of a German study published in PLOS ONE, atrial fibrillation may increase the risk for depression.

On June 28, 2013, the FDA announced approval of Brisdelle (paroxetine) 7.5-mg capsules for the treatment of vasomotor symptoms (VMS) associated with menopause, including hot flashes and night sweats.

In the behavioral health clinic, pharmacists do much more than just fill prescriptions.

A study published online in JAMA Psychiatry found that hospitalization for an infection or an autoimmune disease increased the risk of a subsequent mood disorder diagnosis.

The author's own experience dealing with bipolar disorder has convinced him that we would all be better off if those with mental health issues received better treatment.

A new study has identified a list of widely prescribed medications that should be evaluated to determine how safe and effective they are for their off-label uses.